Statistics

Total Visits

Views
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis77

Select a period of time:

Number of views in the range

Views
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis16

Views

Views
October 20250
November 20250
December 20256
January 20263
February 20260
March 20265
April 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
United Kingdom2
Singapore2
Argentina2
Bolivia1
Brazil1
Canada1
Colombia1
Germany1
Algeria1
 

Top cities views

Views
Ashburn1
Cochabamba1
Frankfurt am Main1
General Levalle1
Helsinki1
Isidro Casanova1
Medellín1
São Paulo1
Sétif1
Toronto1